Clinical Trial Update: Effect of Prophylactic Administration of Oxytocin in Uniject™ on Postpartum Hemorrhage at Home Births in Ghana [NA]

View source ↗

Summary

The clinical trial evaluating prophylactic oxytocin (Uniject) to prevent postpartum hemorrhage at home births in Ghana has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Hemorrhage

Drugs mentioned

• Oxytocin (Uniject) (oxytocin)

Snippet

Sponsor: Johns Hopkins Bloomberg School of Public Health | Conditions: Postpartum Hemorrhage | NA | Status: COMPLETED